{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:55:53Z","timestamp":1789624553324,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ajog.2021.04.217","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T08:40:43Z","timestamp":1618908043000},"page":"392-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Inflammatory breast cancer: early recognition and diagnosis is critical"],"prefix":"10.1016","volume":"225","author":[{"given":"Robert H.","family":"Hester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-6058","authenticated-orcid":false,"given":"Bora","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.04.217_bib1","author":"Susan"},{"key":"10.1016\/j.ajog.2021.04.217_bib2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2021.04.217_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-015-3436-x","article-title":"Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis","volume":"152","author":"Fouad","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajog.2021.04.217_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/annonc\/mdt525","article-title":"Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes","volume":"25","author":"Masuda","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Dis"},{"key":"10.1016\/j.ajog.2021.04.217_bib7","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1200\/JCO.1998.16.12.3731","article-title":"Inflammatory breast cancer and body mass index","volume":"16","author":"Chang","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib8","first-page":"1726","article-title":"Lack of breastfeeding history in parous women with inflammatory breast cancer predicts poor disease-free survival","volume":"8","author":"Stecklein","year":"2017","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204372","article-title":"Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): a comprehensive analysis of the IBC registry at the University of Texas MD Anderson Cancer Center","volume":"13","author":"Fouad","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.04.217_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-016-2369-z","article-title":"Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study","volume":"16","author":"Moslehi","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.31069","article-title":"BRCA mutations in women with inflammatory breast cancer","volume":"124","author":"Gutierrez Barrera","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","article-title":"International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment","volume":"22","author":"Dawood","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib13","first-page":"1437","article-title":"International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference","volume":"9","author":"Ueno","year":"2018","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/1754-9485.12418","article-title":"Review of ultrasound appearance in inflammatory breast cancer: a pictorial essay","volume":"60","author":"Abeywardhana","year":"2016","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145534","article-title":"Inflammatory breast cancer: a distinct clinicopathological entity transcending histological distinction","volume":"11","author":"Raghav","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.04.217_bib16","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.2014.55.1978","article-title":"Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database","volume":"32","author":"Rueth","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib17","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.clbc.2017.06.014","article-title":"Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer","volume":"18","author":"DeSnyder","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/cncr.28550","article-title":"Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer","volume":"120","author":"Akay","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2021.04.217_bib19","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2004.04.068","article-title":"Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy","volume":"22","author":"Low","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/COC.0b013e3182937921","article-title":"Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy","volume":"38","author":"Tsai","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(14)70080-4","article-title":"Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort","volume":"15","author":"Gianni","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2021.04.217_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821004440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821004440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:32:25Z","timestamp":1757590345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821004440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0002937821004440"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.04.217","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory breast cancer: early recognition and diagnosis is critical","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.04.217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}